Javascript must be enabled to continue!
Pathogenesis, Diagnosis, and Treatment of Infectious Rhinosinusitis
View through CrossRef
Rhinosinusitis is a common inflammatory disease of the sinonasal mucosa and paranasal sinuses. The pathogenesis of rhinosinusitis involves a variety of factors, including genetics, nasal microbiota status, infection, and environmental influences. Pathogenic microorganisms, including viruses, bacteria, and fungi, have been proven to target the cilia and/or epithelial cells of ciliated airways, which results in the impairment of mucociliary clearance, leading to epithelial cell apoptosis and the loss of epithelial barrier integrity and immune dysregulation, thereby facilitating infection. However, the mechanisms employed by pathogenic microorganisms in rhinosinusitis remain unclear. Therefore, this review describes the types of common pathogenic microorganisms that cause rhinosinusitis, including human rhinovirus, respiratory syncytial virus, Staphylococcus aureus, Pseudomonas aeruginosa, Aspergillus species, etc. The damage of mucosal cilium clearance and epithelial barrier caused by surface proteins or secreted virulence factors are summarized in detail. In addition, the specific inflammatory response, mainly Type 1 immune responses (Th1) and Type 2 immune responses (Th2), induced by the entry of pathogens into the body is discussed. The conventional treatment of infectious sinusitis and emerging treatment methods including nanotechnology are also discussed in order to improve the current understanding of the types of microorganisms that cause rhinosinusitis and to help effectively select surgical and/or therapeutic interventions for precise and personalized treatment.
Title: Pathogenesis, Diagnosis, and Treatment of Infectious Rhinosinusitis
Description:
Rhinosinusitis is a common inflammatory disease of the sinonasal mucosa and paranasal sinuses.
The pathogenesis of rhinosinusitis involves a variety of factors, including genetics, nasal microbiota status, infection, and environmental influences.
Pathogenic microorganisms, including viruses, bacteria, and fungi, have been proven to target the cilia and/or epithelial cells of ciliated airways, which results in the impairment of mucociliary clearance, leading to epithelial cell apoptosis and the loss of epithelial barrier integrity and immune dysregulation, thereby facilitating infection.
However, the mechanisms employed by pathogenic microorganisms in rhinosinusitis remain unclear.
Therefore, this review describes the types of common pathogenic microorganisms that cause rhinosinusitis, including human rhinovirus, respiratory syncytial virus, Staphylococcus aureus, Pseudomonas aeruginosa, Aspergillus species, etc.
The damage of mucosal cilium clearance and epithelial barrier caused by surface proteins or secreted virulence factors are summarized in detail.
In addition, the specific inflammatory response, mainly Type 1 immune responses (Th1) and Type 2 immune responses (Th2), induced by the entry of pathogens into the body is discussed.
The conventional treatment of infectious sinusitis and emerging treatment methods including nanotechnology are also discussed in order to improve the current understanding of the types of microorganisms that cause rhinosinusitis and to help effectively select surgical and/or therapeutic interventions for precise and personalized treatment.
Related Results
Interleukin-5 Levels in Chronic Rhinosinusitis Patients With and Without Allergy
Interleukin-5 Levels in Chronic Rhinosinusitis Patients With and Without Allergy
<b>Introduction:</b> Chronic rhinosinusitis (CRS) is an inflammation of the nasal mucosa and paranasal sinuses that is present for more than 12 weeks. The pathogenesis ...
Rational approach to the treatment of acute rhinosinusitis in comorbides with dysosmia
Rational approach to the treatment of acute rhinosinusitis in comorbides with dysosmia
Dysosmia is a frequent symptom in acute rhinosinusitis. Post-infectious dysosmia has a large share in the structure of olfactory disorders. The most common is postviral dysosmia. T...
Evidence-based management of acute rhinosinusitis with herbal products
Evidence-based management of acute rhinosinusitis with herbal products
Abstract
Background
The overuse of antibiotics for unjustified indications such as the management of acute uncomplicated rhinosinusitis has contributed to the emergence of antibiot...
Exploring Large Language Models Integration in the Histopathologic Diagnosis of Skin Diseases: A Comparative Study
Exploring Large Language Models Integration in the Histopathologic Diagnosis of Skin Diseases: A Comparative Study
Abstract
Introduction
The exact manner in which large language models (LLMs) will be integrated into pathology is not yet fully comprehended. This study examines the accuracy, bene...
Clinical Presentations of Patients with Chronic Rhinosinusitis
Clinical Presentations of Patients with Chronic Rhinosinusitis
Purpose of Review: Chronic rhinosinusitis (CRS) is denoted as the symptomatic inflammations of sin nasal mucosa persists for ≥12 weeks. The purpose of this study was to review the ...
PREVALENCE AND SEVERITY OF RHINOSINUSITIS AMONG PEOPLE LIVING IN TAIF, SAUDI ARABIA
PREVALENCE AND SEVERITY OF RHINOSINUSITIS AMONG PEOPLE LIVING IN TAIF, SAUDI ARABIA
Background: Chronic rhinosinusitis (CRS) has become a huge burden on healthcare systems of Saudi Arabia. It has been estimated that itsprevalence rate across the world is more than...
Possibilities of usage of modern herbal medicinal product in the treatment of patients with acute viral rhinosinusitis
Possibilities of usage of modern herbal medicinal product in the treatment of patients with acute viral rhinosinusitis
Introduction. The issues of epidemiology, etiopathogenesis, diagnostics and clinic of acute catarrhal rhinosinusitis are considered, the possibility of using the herbal medicinal p...
Probiotic as supplementary therapy for chronic rhinosinusitis
Probiotic as supplementary therapy for chronic rhinosinusitis
Chronic Rhinosinusitis is an inflammation in paranasal sinus and nasal cavity that can last up to a minimum of 12 weeks with prevalence 1% to 12% globally. The etiology of chronic ...

